Researcher
Sana Arnouk
- Keywords (Vrije Universiteit Brussel):Applied biological sciences, biotechnology
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Vrije Universiteit Brussel):Applied immunology, Cancer therapy
- See also: Sana Arnouk (Flanders Institute for Biotechnology)
Affiliations
- Department of Bio-engineering Sciences (Department)
Member
From1 Jan 2024 → Today - Cellular and Molecular Immunology (Research group)
Member
From1 Nov 2023 → 31 Dec 2023 - Department of Bio-engineering Sciences (Department)
Member
From1 Nov 2019 → 31 Oct 2023 - Department of Bio-engineering Sciences (Department)
Member
From8 Apr 2019 → 31 Oct 2019 - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From30 Oct 2018 → 19 Dec 2023 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 2018 → 31 Oct 2019 - Van Ginderachter Lab (Research group)
Member
From1 Oct 2018 → Today - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From30 Sep 2016 → 13 Sep 2018
Projects
1 - 1 of 1
- A novel cancer therapy that selectively targets tumor-infiltrating regulatory T cellsFrom1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
Publications
1 - 8 of 8
- Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting(2023)
Authors: Marco Erreni, Francesca D'Autilia, Roberta Avigni, Evangelia Bolli, Sana M Arnouk, Kiavash Movahedi, Pieterjan Debie, Achille Anselmo, Raffaella Parente, Cécile Vincke, et al.
Pages: 355-373 - Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment(2022)
Authors: Máté Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Jan Brughmans, Isabelle Scheyltjens, Ali Talebi, Robin Maximilian Awad, Yvon Elkrim, et al.
- Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages(2022)
Authors: Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeerk, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M Arnouk, Ahmed E. I. Hamouda, et al.
Pages: 3785-3801 - Imaging and therapeutic targeting of the tumor immune microenvironment with biologics(2022)
Authors: Sana M Arnouk, Timo W M De Groof, Jo Van Ginderachter
- IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D(2021)
Authors: Máté Kiss, Lieselotte Vande Walle, Pedro H V Saavedra, Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, et al.
Pages: 309-323 - Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy(2020)
Authors: Els Lebegge, Sana M Arnouk, Pauline Bardet, Máté Kiss, Geert Raes, Jo Van Ginderachter
Pages: 1-14 - Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors(2019)
Authors: Evangelia Bolli, Matthias D'Huyvetter, Aleksandar Murgaski, Danielle Berus, Geert Stangé, Emile Clappaert, Sana M Arnouk, Ana Rita Pombo Antunes, Ahmet Krasniqi, Tony Lahoutte, et al.
Pages: 1-11 - Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's(2019)
Authors: Aleksandar Murgaski, Pauline Bardet, Sana M Arnouk, Emile Clappaert, Damya Laoui